These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3898291)

  • 1. Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study.
    Bolla K; Djawari D; Kokoschka EM; Petres J; Lidén S; Gonseth R; Amblard P; Bernengo MG; Bonerandi JJ; Claudy A
    Surv Immunol Res; 1985; 4 Suppl 1():37-47. PubMed ID: 3898291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
    DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
    Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
    Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
    Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():87-93. PubMed ID: 3898298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised study.
    Malaise MG; Hauwaert C; Franchimont P; Danneskiold-Samsoe B; Bach-Andersen R; Gross D; Gerber H; Gerschpacher H; Stocker H; Bolla K
    Lancet; 1985 Apr; 1(8433):832-6. PubMed ID: 2858708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thymopentin on the mortality and immune response after an experimental herpes simplex infection in mice.
    Cappel R; de Cuyper F; De Neef K; Höbel W; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():48-57. PubMed ID: 3898292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymopentin in chronic Trichophyton rubrum infection.
    Molin L; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymopentin therapy reduces the clinical severity of atopic dermatitis.
    Leung DY; Hirsch RL; Schneider L; Moody C; Takaoka R; Li SH; Meyerson LA; Mariam SG; Goldstein G; Hanifin JM
    J Allergy Clin Immunol; 1990 May; 85(5):927-33. PubMed ID: 2185294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
    Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
    Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
    Franchimont P; Hauwaert C; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymopentin treatment in AIDS and pre-AIDS patients.
    Clumeck N; Cran S; Van de Perre P; Mascart-Lemone F; Duchateau J; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():58-62. PubMed ID: 3898293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with thymopentin in the treatment of periarthritis humeroscapularis, tendinitis, and gonarthrosis by local infiltration.
    Pipino F; Vittore D
    Arzneimittelforschung; 1988 Jan; 38(1):116-9. PubMed ID: 3284530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of the CD4/CD8 lymphocyte ratio and increased B lymphocytes in long standing diabetic patients following therapy with thymopentin.
    Pozzilli P; Visalli N; Cavallo MG; Beales P; Negri M; Ghirlanda G; Papa V; Andreani D
    Diabetes Res; 1987 Oct; 6(2):51-6. PubMed ID: 2962799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymopentin treatment in genital warts of long duration.
    Fransen L; Anthoons J; Hoogewijs G; Bolla K
    Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosis.
    Giordano N; Biasi G; Taddeo A; Marcolongo R; Bertelletti D
    Clin Rheumatol; 1989 Jun; 8(2):293-4. PubMed ID: 2667863
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of recurrent herpes simplex with thymopoietin-pentapeptide].
    Djawari D; Bolla K; Haneke E
    Dtsch Med Wochenschr; 1984 Mar; 109(13):496-8. PubMed ID: 6368167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thymopentin and immune response in patients with cancer].
    Petronella P; Ferrone R; Freda F; Valeriani G
    Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
    Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
    G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
    [No Abstract]   [Full Text] [Related]  

  • 19. Thymopentin treatment in a patient with pluriorificial pyoderma vegetans.
    Simon M; Djawari D; Horstein OP; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():125-8. PubMed ID: 3898284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymopentin in the treatment of cutaneous melanoma].
    Trevisan G; Agolzer A
    G Ital Dermatol Venereol; 1989 May; 124(5):245-9. PubMed ID: 2695455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.